CTCBIO Inc (060590) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.079x

Based on the latest financial reports, CTCBIO Inc (060590) has a cash flow conversion efficiency ratio of 0.079x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.64 Billion ≈ $3.82 Million USD) by net assets (₩71.75 Billion ≈ $48.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can CTCBIO Inc fund operations to measure how many days the company can operate on defensive assets alone.

CTCBIO Inc - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how CTCBIO Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CTCBIO Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CTCBIO Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Gmb Korea KO:013870	0.023x
SDS Group Bhd KLSE:0212	0.083x
Prestige Wealth Inc. NASDAQ:AURE	-0.001x
Spectris PLC LSE:SXS	0.048x
Dsr Wire KO:069730	0.055x
Immutep Ltd AU:IMM	-0.233x
Hastings Technology Metals Ltd AU:HAS	-0.035x
Firetrade Engineering PCL BK:FTE	0.045x

Annual Cash Flow Conversion Efficiency for CTCBIO Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of CTCBIO Inc from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see market value of CTCBIO Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩69.62 Billion ≈ $47.18 Million	₩4.50 Billion ≈ $3.05 Million	0.065x	-40.69%
2023-12-31	₩75.44 Billion ≈ $51.13 Million	₩8.22 Billion ≈ $5.57 Million	0.109x	-42.66%
2022-12-31	₩95.96 Billion ≈ $65.03 Million	₩18.22 Billion ≈ $12.35 Million	0.190x	+150.02%
2021-12-31	₩85.01 Billion ≈ $57.61 Million	₩6.46 Billion ≈ $4.38 Million	0.076x	+1036.38%
2020-12-31	₩76.32 Billion ≈ $51.72 Million	₩510.09 Million ≈ $345.68K	0.007x	-70.18%
2019-12-31	₩74.74 Billion ≈ $50.65 Million	₩1.68 Billion ≈ $1.14 Million	0.022x	+178.74%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩-2.47 Billion ≈ $-1.68 Million	-0.028x	-813.17%
2017-12-31	₩73.98 Billion ≈ $50.14 Million	₩295.30 Million ≈ $200.12K	0.004x	-94.71%
2016-12-31	₩90.89 Billion ≈ $61.60 Million	₩6.86 Billion ≈ $4.65 Million	0.076x	+420.86%
2015-12-31	₩99.14 Billion ≈ $67.19 Million	₩1.44 Billion ≈ $974.04K	0.014x	+456.42%
2014-12-31	₩85.49 Billion ≈ $57.94 Million	₩-347.74 Million ≈ $-235.66K	-0.004x	-113.69%
2013-12-31	₩92.23 Billion ≈ $62.50 Million	₩2.74 Billion ≈ $1.86 Million	0.030x	--

About CTCBIO Inc

KQ:060590 Korea Biotechnology

Market Cap

$51.04 Million

₩75.31 Billion KRW

Market Cap Rank

#21869 Global

#1318 in Korea

Share Price

₩3150.00

Change (1 day)

-4.83%

52-Week Range

₩3045.00 - ₩7450.00

All Time High

₩18000.00